From: A new score predicting the survival of patients with spinal cord compression from myeloma
Survival at 6 months (%) | Survival at 12 months (%) | Median survival time (months) | p-value | |
---|---|---|---|---|
Age | ||||
≤ 63 years | 82 | 76 | 45 | |
≥ 64 years | 88 | 73 | 57 | 0.92 |
Gender | ||||
i Female | 76 | 61 | 37 | |
Male | 90 | 83 | 45 | 0.29 |
ECOG Performance status | ||||
1-2 | 91 | 81 | 57 | |
3-4 | 73 | 60 | 14 | 0.006 |
Number of involved vertebrae | ||||
1-2 | 83 | 73 | 70 | |
≥ 3 | 87 | 77 | 37 | 0.95 |
Ambulatory status prior to radiotherapy | ||||
Not Ambulatory | 70 | 56 | 14 | |
Ambulatory before RT | 90 | 81 | 57 | 0.005 |
Other bone lesions | ||||
No | 98 | 84 | not reached | |
Yes | 76 | 69 | 32 | 0.019 |
Extraosseous lesions | ||||
No | 86 | 75 | 45 | |
Yes | 67 | not available | not available | 0.35 |
Interval from cancer diagnosis to radiotherapy of MSCC | ||||
≤ 15 months | 90 | 77 | 45 | |
> 15 months | 80 | 73 | 32 | 0.19 |
Time developing motor deficits | ||||
1-14 days | 80 | 66 | 19 | |
> 14 days | 89 | 81 | 57 | 0.27 |
Radiation regimen | ||||
Short-course radiotherapy | 81 | 72 | 45 | |
Longer-course radiotherapy | 87 | 76 | 57 | 0.97 |